← Back to Search

Smart Mattress Device for Epilepsy Prevention (Korus Trial)

N/A

Waitlist Available

Led By Jong Woo Lee, MD, PhD

Research Sponsored by Brigham and Women's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adults age 18-65

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 seconds

Awards & highlights

Korus Trial Summary

This trial tests if a smart mattress can accurately detect body position and reposition people from prone to recovery position. #smartmattress #feasibilitystudy

Who is the study for?

This trial is for healthy adults aged 18-65 who often sleep on their stomachs. It's not suitable for those with neurological, psychiatric, cardiac issues, bone diseases like osteoporosis, significant orthopedic problems, a history of falls or sleep disorders. People on certain medications or drugs and those with extreme body weights or blood pressure are also excluded.Check my eligibility

What is being tested?

The Korus study tests a smart mattress designed to prevent SUDEP by detecting the user's sleeping position and automatically repositioning them from prone (face down) to sideways if necessary. Participants will simulate various sleeping positions to assess the device's accuracy and functionality.See study design

What are the potential side effects?

Since this trial involves using a non-invasive device rather than medication, side effects are minimal but may include discomfort from being moved by the mattress or potential anxiety about using an automated system during sleep.

Korus Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Korus Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 seconds

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 seconds

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 seconds for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Body position detection

Number of subjects correctly repositioned from the prone to recovery position

Korus Trial Design

1Treatment groups

Experimental Treatment

Group I: Control subjectsExperimental Treatment1 Intervention

The subject will lie down on the Korus smart mattress. Korus will detect when the subject is in a prone (face-down) position and reposition the subject into a recovery (sideways) position.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor

1,614 Previous Clinical Trials

11,470,825 Total Patients Enrolled

11 Trials studying Epilepsy

54,303 Patients Enrolled for Epilepsy

Jong Woo Lee, MD, PhDPrincipal InvestigatorBrigham and Women's Hospital

3 Previous Clinical Trials

78 Total Patients Enrolled

2 Trials studying Epilepsy

66 Patients Enrolled for Epilepsy

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are senior citizens excluded from participating in this scientific evaluation?

"As per the trial's requirements, participants must be between 18 to 65 years old. There are 102 studies specifically targeting those below 18 and 163 for seniors aged above 65."

Answered by AI

Are there still opportunities for people to join this research experiment?

"As detailed on clinicaltrials.gov, this research study is no longer open to applicants at the moment. Initially posted on July 1st 2024 and last updated November 14th 2023, the trial has since been closed off from new participants; however there are many others recruiting right now with a collective 246 trials available for enrollment."

Answered by AI

Do I meet the criteria to participate in this research initiative?

"This study requires participants to meet the following criteria: suffering from epilepsy and aged 18-65. At this time, 10 individuals are being sought out for enrollment in this trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Korus: a Device to Prevent Sudden Unexpected Death in Epilepsy (SUDEP)

Jong Woo Lee 2024. "Korus: a Device to Prevent Sudden Unexpected Death in Epilepsy (SUDEP)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06135285.

All > Epilepsy